The CRO concept sector declined. Zhaoyan New Pharmaceutical, Gloria Ying, and Lingkang Pharmaceutical fell to a standstill; Baiosetu fell by more than 13%; Prius, Wisdom Pharmaceuticals, and Baihua Pharmaceuticals all fell sharply.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.